Reuters logo
1 个月前
BRIEF-Supernus says Shire receives FDA approval for Mydayis for ADHD
2017年6月21日 / 下午4点52分 / 1 个月前

BRIEF-Supernus says Shire receives FDA approval for Mydayis for ADHD

1 分钟阅读

June 21 (Reuters) - Supernus Pharmaceuticals Inc:

* Supernus announces that its partner Shire receives FDA approval for Mydayis™ for ADHD

* Shire expects to make Mydayis commercially available in United States in Q3 of 2017

* Based on agreement between Supernus, Shire, Shire will pay to Supernus single digit percentage royalty on net sales of product Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below